Introduction
The change in microglia from the resting to the activated state is known to be an integral part of neuroinflammation [1] . Functions of activated microglia include: clearance of apoptotic cells and extracellular pathogens, removal of degenerating neurons and extracellular proteins, and cytokine/chemokine production. When microglia become activated, cellular morphology changes and expression of translocator protein (TSPO) 18 kDa is increased [1] , thereby making expression of TSPO a marker for neuroinflammation.
Over the past several years, the radioligand N-(2,5-dimethoxybenzyl)-N-(5-fluoro-2-phenoxyphenyl) acetamide labeled with carbon-11 (abbreviated as [ 11 C]DAA1106) has emerged as a reliable radiotracer for examining neuroinflammation with positron emission tomography (PET) scanning in vivo [2] . This radiotracer labels TSPO with high affinity, and this mitochondrial protein is found in brain and peripheral tissues [3] . Specific binding of DAA1106 has been found to correlate with the presence of activated microglia identified by immunohistochemistry in situ [4] . Furthermore, immunohistochemistry combined with autoradiography in brain tissues, as well as correlational analyses, show that increased DAA1106 binding in the 
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Nuclear Medicine and Biology j o u r n a l h o m e p a g e : w w w . e l s e v i e r . c o m / l o c a t e / n u c m e d b i o central nervous system corresponds mainly to the presence of activated microglia [2, 5] . [ 11 C]DAA1106 was originally developed as a radiotracer for measuring inflammation [6] [7] [8] , and was determined to have higher binding than previously used radiotracers [2, 4, 9, 10] . In animal studies using this radiotracer [10] , binding was significant in cortex, brainstem, hippocampus, and cerebellum, and neural destruction was found to result in increased binding. In addition, specific binding was estimated to be 80% of total binding [10] , which is a favorable property for a radiotracer. PET scanning and [ 11 C]DAA1106 have been used in a growing number of studies to examine conditions thought to be associated with neuroinflammation. For example, this method was used recently to demonstrate widespread neuroinflammation in patients with mild cognitive impairment and Alzheimer's Disease (AD) compared to agematched controls [11] . Similarly, a prior study found increased [ 11 produced using a TR-19 cyclotron by proton bombardment of 10% hydrogen in nitrogen gas. The radiochemical purity was N 99%, with mean specific activity (±SD) of 17.6 ± 13.1 Ci/μmol.
Participants
Twelve healthy participants (ten men and two women; mean age 53 ± 14 y; age range 26 to 65 y) completed the study. Participants were veterans, and weighed 88 ± 17 kg (range 67 to 112 kg). Each participant provided written informed consent using a form approved by the local institutional review board at a screening visit prior to PET scanning. Participants were generally healthy, based on their reports, a physical examination, and reviews of medical records, which included routine laboratory tests. Exclusion criteria consisted of Values are mean ± SD for 10 male and 2 female participants. The dose for ovaries shown here is based on all participants, while that of testes is based on male participants only.
conditions that might affect a participant's ability to tolerate study procedures, such as severe liver or kidney disease, current mental illness, or cardiovascular disease. Participants were also excluded if they were regularly taking anti-inflammatory medication or were pregnant. Breathalyzer and urine toxicology screens were obtained for all participants, and urine pregnancy tests were obtained for women of childbearing potential. Potential participants were excluded from undergoing PET scanning if any of these tests were positive.
PET/CT acquisition and PET image analysis
Participants underwent full body dynamic There was minimal acquisition delay between bed positions, while there was a 5-10 second delay between scans for the return movement of the bed. Each bed position had 50% overlap with the previous bed position (other than the first bed position). Mean scanning times were 6, 12, 18, 30, 42, 54, 78, and 102 minutes after injection. Participants were continuously scanned and did not urinate during the procedure. PET images were acquired in time-of-flight mode and reconstructed with the RAMLA iterative algorithm [19] . Images were corrected for scatter and attenuation based on the CT scan.
Regions of interest (ROIs) were drawn manually on the images, and time activity curves (TACs) were obtained for brain, gallbladder contents, small intestine, stomach wall, heart contents, heart wall, kidneys, liver, lungs, muscle, pancreas, red marrow, spleen, thyroid, and urinary bladder contents. The TACs were integrated to yield the number of disintegrations per mCi in each source organ. The total number of disintegrations per mCi in the body is given by t 1/2 /ln 2 = 0.489 hr. The numbers for the individual organs were scaled so that the total has this value. This step removed uncertainty in the activity that reached the circulation. OLINDA/EXM (Organ Level INternal Dose Assessment/EXponential Modeling) 1.1 [20] was used to compute radiation doses to the target organs as well as effective dose (ED) and effective dose equivalent (EDE), using the adult male (n = 10) and female (n = 2) models.
Results
Participants did not report any subjective effects following the injected dose of [ 11 C]DAA1106. No adverse events or serious adverse events occurred following radiotracer injection, and no significant changes in vital signs or clinical laboratory tests (CBC and chemistry panel) were found from before to after PET scanning. The highest absorbed doses were to the heart wall, kidney, liver, pancreas, and spleen (Table 1) . These organs were visible on 0-6 min 22-36 min 50-64 min 93-118 min 67-92 min participant PET scans (Fig. 2) . The total ED and EDE were 4.06 ± 0.58 μSv/MBq and 5.89 ± 0.83 μSv/MBq, respectively. Time activity curves (TACs) (Fig. 3) revealed that peak dose rates are during the first scan (at 6 min) for all organs other than the urinary bladder wall, which had its peak dose rate during the fourth scan (at 30 min). The liver, lungs, and kidneys received the highest percentages of the injected dose. The following is worth noting. OLINDA computes target-organ doses for a hypothetical uterus and hypothetical ovaries, even for the male model. If the equivalent dose to the "ovaries" exceeds that to the testes, the former is used in the EDE and ED calculations. If the "uterus" receives a sufficient equivalent dose, it is used in the EDE and/or ED calculations. For DAA in our male subjects, OLINDA uses "ovaries" in lieu of testes in the EDE and ED calculations and uses "uterus" in the ED calculation. If we modify the calculations so that, for the male subjects (n = 10), testes is used for EDE and ED and "uterus" is not used, EDE (ED) is reduced by 14% (13%).
Discussion
The recently developed radiotracer [ for examining microglial activation (a marker for neuroinflammation) repeatedly over time, which could be useful for research into conditions that are marked by neuroinflammation (e.g., head trauma [22, 23] or multiple sclerosis [24, 25] [28] . In addition, the target organs with the highest doses from [ 11 C]DAA1106 (heart wall, kidneys, liver, pancreas, and spleen) are similar to the target organs most commonly found to have relatively high dose in other studies of TSPO radiotracers in humans [26] [27] [28] [29] and laboratory animals [29, 30] . While it is somewhat unexpected that the heart wall would have a relatively high dose, this finding is consistent with prior research using radiotracers for TSPO, where this organ has a moderate-to-high [26, 27, 29, 30] dose, due to persistent activity in the myocardium. The consistency of this finding may indicate that specific binding in this organ contributes to the absorbed dose. In addition to [ 11 C]DAA1106 having slightly lower ED and EDE values than most TSPO radiotracers, this radiotracer has other favorable properties. To our knowledge, the most commonly used TSPO radiotracer for examining neuroinflammation in a variety of conditions in humans is [ 11 C]PK11195 (e.g., [31] [32] [33] [34] [35] [36] specific binding in brain [10] . In a study directly comparing DAA1106 with PK11195, DAA1106 was found to have a lower dissociation constant [2, 4] and higher specific binding at the site of an experimentally induced lesion than PK11195 [2] , which led the study authors to conclude that DAA1106 may be a better radioligand for human PET studies than the commonly used PK11195. This last point has also been suggested as being advantageous for DAA1106 for visualizing TSPO levels in conditions characterized by mild neuroinflammation [37] . Thus, in addition to other similar radiotracers, [
11 C] DAA1106 may prove useful for studying and monitoring disease progression and therapy response in conditions associated with neuroinflammation [38] , such as head trauma [22, 23] and multiple sclerosis [24, 25] .
Conclusion
The biodistribution and radiation dosimetry of 
